<?xml version="1.0"?>
<?xml-stylesheet type='text/xsl' href='../../ld1.xsl'?>
<LOBBYINGDISCLOSURE1>
   <imported>N</imported>
   <pages>3</pages>
   <regType>2</regType>
   <organizationName>Gephardt Group Government Affairs</organizationName>
   <prefix></prefix>
   <firstName></firstName>
   <lastName></lastName>
   <address1>1101 K Street, NW</address1>
   <address2>Suite 310</address2>
   <city>Washington</city>
   <state>DC</state>
   <zip>20005</zip>
   <zipext></zipext>
   <country>USA</country>
   <principal_city></principal_city>
   <principal_state></principal_state>
   <principal_zip></principal_zip>
   <principal_zipext></principal_zipext>
   <principal_country></principal_country>
   <registrantGeneralDescription>consulting, government affairs</registrantGeneralDescription>
   <selfSelect>N</selfSelect>
   <clientName>Teva Pharmaceuticals USA, Inc.</clientName>
   <clientAddress>1090 Horsham Road</clientAddress>
   <clientCity>North Wales</clientCity>
   <clientState>PA</clientState>
   <clientZip>19454</clientZip>
   <clientZipExt></clientZipExt>
   <clientCountry>USA</clientCountry>
   <prinClientCity></prinClientCity>
   <prinClientState></prinClientState>
   <prinClientZip></prinClientZip>
   <prinClientZipExt></prinClientZipExt>
   <prinClientCountry></prinClientCountry>
   <clientGeneralDescription>pharmaceutical manufacturer</clientGeneralDescription>
   <senateID>315717</senateID>
   <houseID>392150084</houseID>
   <lobbyists>
      <lobbyist>
         <lobbyistFirstName>Richard</lobbyistFirstName>
         <lobbyistLastName>Gephardt</lobbyistLastName>
         <lobbyistSuffix></lobbyistSuffix>
         <coveredPosition>Member of Congress</coveredPosition>
         <lobbyistNew>Y</lobbyistNew>
      </lobbyist>
      <lobbyist>
         <lobbyistFirstName>Thomas</lobbyistFirstName>
         <lobbyistLastName>O'Donnell</lobbyistLastName>
         <lobbyistSuffix></lobbyistSuffix>
         <coveredPosition>Chief of Staff, House Majority Leader</coveredPosition>
         <lobbyistNew>Y</lobbyistNew>
      </lobbyist>
      <lobbyist>
         <lobbyistFirstName>Janice</lobbyistFirstName>
         <lobbyistLastName>O'Connell</lobbyistLastName>
         <lobbyistSuffix></lobbyistSuffix>
         <coveredPosition>Prof Staff, Senate Foreign Relations and Banking Committees</coveredPosition>
         <lobbyistNew>Y</lobbyistNew>
      </lobbyist>
      <lobbyist>
         <lobbyistFirstName>Andrea</lobbyistFirstName>
         <lobbyistLastName>King</lobbyistLastName>
         <lobbyistSuffix></lobbyistSuffix>
         <coveredPosition>Domestic Pol Adv, House Dem Leader; Staff Dir, Rep. Gephardt</coveredPosition>
         <lobbyistNew>Y</lobbyistNew>
      </lobbyist>
      <lobbyist>
         <lobbyistFirstName>Robert</lobbyistFirstName>
         <lobbyistLastName>Epplin</lobbyistLastName>
         <lobbyistSuffix></lobbyistSuffix>
         <coveredPosition>LA, Sen. Packwood; Prof Staff, Senate Finance Committee;</coveredPosition>
         <lobbyistNew>Y</lobbyistNew>
      </lobbyist>
      <lobbyist>
         <lobbyistFirstName>Robert</lobbyistFirstName>
         <lobbyistLastName>Epplin</lobbyistLastName>
         <lobbyistSuffix></lobbyistSuffix>
         <coveredPosition>Analyst, OMB Budget Review Division; LA and LD, Sen. Smith;</coveredPosition>
         <lobbyistNew>Y</lobbyistNew>
      </lobbyist>
      <lobbyist>
         <lobbyistFirstName>Robert</lobbyistFirstName>
         <lobbyistLastName>Epplin</lobbyistLastName>
         <lobbyistSuffix></lobbyistSuffix>
         <coveredPosition>LD, Sen. Collins</coveredPosition>
         <lobbyistNew>Y</lobbyistNew>
      </lobbyist>
      <lobbyist>
         <lobbyistFirstName>Michael</lobbyistFirstName>
         <lobbyistLastName>Messmer</lobbyistLastName>
         <lobbyistSuffix></lobbyistSuffix>
         <coveredPosition>Policy Advisor and Research Assoc, House Dem Policy Comm;</coveredPosition>
         <lobbyistNew>Y</lobbyistNew>
      </lobbyist>
      <lobbyist>
         <lobbyistFirstName>Michael</lobbyistFirstName>
         <lobbyistLastName>Messmer</lobbyistLastName>
         <lobbyistSuffix></lobbyistSuffix>
         <coveredPosition>Executive Assistant, House Democratic Leader</coveredPosition>
         <lobbyistNew>Y</lobbyistNew>
      </lobbyist>
      <lobbyist>
         <lobbyistFirstName></lobbyistFirstName>
         <lobbyistLastName></lobbyistLastName>
         <lobbyistSuffix></lobbyistSuffix>
         <coveredPosition></coveredPosition>
         <lobbyistNew>Y</lobbyistNew>
      </lobbyist>
      <lobbyist>
         <lobbyistFirstName></lobbyistFirstName>
         <lobbyistLastName></lobbyistLastName>
         <lobbyistSuffix></lobbyistSuffix>
         <coveredPosition></coveredPosition>
         <lobbyistNew>Y</lobbyistNew>
      </lobbyist>
   </lobbyists>
   <alis>
      <ali_Code>CPT</ali_Code>
      <ali_Code>HCR</ali_Code>
      <ali_Code>TRD</ali_Code>
      <ali_Code></ali_Code>
      <ali_Code></ali_Code>
      <ali_Code></ali_Code>
      <ali_Code></ali_Code>
      <ali_Code></ali_Code>
      <ali_Code></ali_Code>
      <ali_Code></ali_Code>
      <ali_Code></ali_Code>
      <ali_Code></ali_Code>
      <ali_Code></ali_Code>
      <ali_Code></ali_Code>
      <ali_Code></ali_Code>
      <ali_Code></ali_Code>
      <ali_Code></ali_Code>
      <ali_Code></ali_Code>
   </alis>
   <specific_issues>FDA and healthcare policy; international trade agreements</specific_issues>
   <affiliatedUrl></affiliatedUrl>
   <affiliatedOrgs>
      <affiliatedOrg>
         <affiliatedOrgName></affiliatedOrgName>
         <affiliatedOrgAddress></affiliatedOrgAddress>
         <affiliatedOrgCity></affiliatedOrgCity>
         <affiliatedOrgState></affiliatedOrgState>
         <affiliatedOrgZip></affiliatedOrgZip>
         <affiliatedOrgCountry></affiliatedOrgCountry>
         <affiliatedPrinOrgCity></affiliatedPrinOrgCity>
         <affiliatedPrinOrgState></affiliatedPrinOrgState>
         <affiliatedPrinOrgCountry></affiliatedPrinOrgCountry>
      </affiliatedOrg>
      <affiliatedOrg>
         <affiliatedOrgName></affiliatedOrgName>
         <affiliatedOrgAddress></affiliatedOrgAddress>
         <affiliatedOrgCity></affiliatedOrgCity>
         <affiliatedOrgState></affiliatedOrgState>
         <affiliatedOrgZip></affiliatedOrgZip>
         <affiliatedOrgCountry></affiliatedOrgCountry>
         <affiliatedPrinOrgCity></affiliatedPrinOrgCity>
         <affiliatedPrinOrgState></affiliatedPrinOrgState>
         <affiliatedPrinOrgCountry></affiliatedPrinOrgCountry>
      </affiliatedOrg>
      <affiliatedOrg>
         <affiliatedOrgName></affiliatedOrgName>
         <affiliatedOrgAddress></affiliatedOrgAddress>
         <affiliatedOrgCity></affiliatedOrgCity>
         <affiliatedOrgState></affiliatedOrgState>
         <affiliatedOrgZip></affiliatedOrgZip>
         <affiliatedOrgCountry></affiliatedOrgCountry>
         <affiliatedPrinOrgCity></affiliatedPrinOrgCity>
         <affiliatedPrinOrgState></affiliatedPrinOrgState>
         <affiliatedPrinOrgCountry></affiliatedPrinOrgCountry>
      </affiliatedOrg>
      <affiliatedOrg>
         <affiliatedOrgName></affiliatedOrgName>
         <affiliatedOrgAddress></affiliatedOrgAddress>
         <affiliatedOrgCity></affiliatedOrgCity>
         <affiliatedOrgState></affiliatedOrgState>
         <affiliatedOrgZip></affiliatedOrgZip>
         <affiliatedOrgCountry></affiliatedOrgCountry>
         <affiliatedPrinOrgCity></affiliatedPrinOrgCity>
         <affiliatedPrinOrgState></affiliatedPrinOrgState>
         <affiliatedPrinOrgCountry></affiliatedPrinOrgCountry>
      </affiliatedOrg>
      <affiliatedOrg>
         <affiliatedOrgName></affiliatedOrgName>
         <affiliatedOrgAddress></affiliatedOrgAddress>
         <affiliatedOrgCity></affiliatedOrgCity>
         <affiliatedOrgState></affiliatedOrgState>
         <affiliatedOrgZip></affiliatedOrgZip>
         <affiliatedOrgCountry></affiliatedOrgCountry>
         <affiliatedPrinOrgCity></affiliatedPrinOrgCity>
         <affiliatedPrinOrgState></affiliatedPrinOrgState>
         <affiliatedPrinOrgCountry></affiliatedPrinOrgCountry>
      </affiliatedOrg>
      <affiliatedOrg>
         <affiliatedOrgName></affiliatedOrgName>
         <affiliatedOrgAddress></affiliatedOrgAddress>
         <affiliatedOrgCity></affiliatedOrgCity>
         <affiliatedOrgState></affiliatedOrgState>
         <affiliatedOrgZip></affiliatedOrgZip>
         <affiliatedOrgCountry></affiliatedOrgCountry>
         <affiliatedPrinOrgCity></affiliatedPrinOrgCity>
         <affiliatedPrinOrgState></affiliatedPrinOrgState>
         <affiliatedPrinOrgCountry></affiliatedPrinOrgCountry>
      </affiliatedOrg>
   </affiliatedOrgs>
   <foreignEntities>
      <foreignEntity>
         <name>Orvet UK</name>
         <address>Leeds Business Park, 18 Brutcliffe Way</address>
         <city>Morely Leeds</city>
         <state></state>
         <country>GBR</country>
         <prinCity></prinCity>
         <prinState></prinState>
         <prinCountry></prinCountry>
         <contribution>0.00</contribution>
         <ownership_Percentage>100</ownership_Percentage>
      </foreignEntity>
      <foreignEntity>
         <name>Teva Pharmaceuticals Europe BV</name>
         <address>PO Box 306</address>
         <city>Mijdrecht</city>
         <state></state>
         <country>NED</country>
         <prinCity></prinCity>
         <prinState></prinState>
         <prinCountry></prinCountry>
         <contribution>0.00</contribution>
         <ownership_Percentage>100</ownership_Percentage>
      </foreignEntity>
      <foreignEntity>
         <name>Teva Pharmaceutical Industries, Ltd.</name>
         <address>5 Basel Street</address>
         <city>Petach Tikva</city>
         <state></state>
         <country>ISR</country>
         <prinCity></prinCity>
         <prinState></prinState>
         <prinCountry></prinCountry>
         <contribution>0.00</contribution>
         <ownership_Percentage>100</ownership_Percentage>
      </foreignEntity>
      <foreignEntity>
         <name></name>
         <address></address>
         <city></city>
         <state></state>
         <country></country>
         <prinCity></prinCity>
         <prinState></prinState>
         <prinCountry></prinCountry>
         <contribution></contribution>
         <ownership_Percentage></ownership_Percentage>
      </foreignEntity>
      <foreignEntity>
         <name></name>
         <address></address>
         <city></city>
         <state></state>
         <country></country>
         <prinCity></prinCity>
         <prinState></prinState>
         <prinCountry></prinCountry>
         <contribution></contribution>
         <ownership_Percentage></ownership_Percentage>
      </foreignEntity>
   </foreignEntities>
   <reportYear>2014</reportYear>
   <reportType>RR</reportType>
   <effectiveDate>01/01/2014</effectiveDate>
   <printedName>Thomas J. O'Donnell, Managing Partner</printedName>
   <signedDate>01/13/2014</signedDate>
</LOBBYINGDISCLOSURE1>